Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Relpax, Relert
Eletriptan is a selective serotonin 5-HT1B/1D receptor agonist used to treat acute migraine attacks with or without aura. It belongs to the triptan class of drugs, which work by constricting blood vessels in the brain and reducing inflammation, thus relieving migraine pain. Eletriptan is not intended for preventative use.
For the acute treatment of migraine attacks with or without aura.
Outcome:
Increased risk of vasospasm
Mechanism:
Additive vasoconstrictive effects
Outcome:
Weakness, hyperreflexia, and incoordination
Mechanism:
Increased serotonergic activity
Outcome:
Potential additive effect
Mechanism:
May enhance analgesic effect
Most likely new formulation: extended-release formulation for migraine prevention (Year: 2026, 70% confidence)
Based on current usage trends and safety profile, eletriptan is likely to maintain its current FDA approval status with no major changes expected (95% confidence).
Triptan, 5-HT1 Receptor Agonist, Antimigraine Agent
Tryptamine Derivative